A rating of 92 puts ImmunoGen, Inc. (IMGN) near the top of the Biotechnology industry according to InvestorsObserver. ImmunoGen, Inc.'s score of 92 means it scores higher than 92% of stocks in the industry. ImmunoGen, Inc. also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 80 out of the 148 industries.
IMGN has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on IMGN!